Metastatic prostate cancer presenting as tumour-induced osteomalacia

10Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

Abstract

Tumour-induced osteomalacia (TIO), or oncogenic osteomalacia, is a paraneoplastic syndrome marked by hypophosphataemia, renal phosphate wasting, bone pain, weakness, and fractures. The syndrome has been reported with both benign and malignant tumours including parotid gland basal cell tumours, thyroid carcinomas, colon adenocarcinomas, and prostate cancer. Often, the syndrome is marked by an insidious course during which patients present with generalised bony pain and weakness, which do not resolve until the underlying tumour is identified and treated. We present a case of a patient with Parkinson's disease whose subacute weakness, lower extremity paresis, and renal phosphate wasting led to the synchronous diagnosis of metastatic prostate adenocarcinoma and TIO.

Author supplied keywords

Cite

CITATION STYLE

APA

Layman, A. A. K., Joshi, S., & Shah, S. (2019). Metastatic prostate cancer presenting as tumour-induced osteomalacia. BMJ Case Reports, 12(7). https://doi.org/10.1136/bcr-2019-229434

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free